The Institute for the Hospital Remuneration System has published the list of technologies receiving innovation funding in the year 2017 in Germany
The Institute for the Hospital Remuneration System (InEK), being responsible for the development of the G-DRG system, finished the evaluation of the requests for innovation funding (NUB), which were sent in until 31st October 2016. Out of the 686 unique from a total of 36,675 requests, 154 (22%) received the positive status 1, 67 (10%) of them were methods based on medical devices, which allows the requesting hospitals to negotiate with the sickness funds over innovation funding.
Out of the 686 unique from a total of 36,675 requests, 154 (22%) received the positive status 1, 67 (10%) of them were methods based on medical devices, which allows the requesting hospitals to negotiate with the sickness funds over innovation funding. Among the 67 methods, a median of 15 hospitals applied for innovation funding per technology, in a range from 1 to 411. A histogram visualizing the distribution can be found in figure 1.
Categorized into technology-related groups, it can be observed that cardiovascular technologies are by far the most commonly funded technologies (Figure 2).
With the introduction of § 137h SGB V in 2016, hospitals are now obliged to hand in an extensive scientific dossier to the Federal Joint Committee (G-BA) at the same time when applying for NUB for the first time for methods based on high-risk medical devices. For that reason, InEK introduced a new column indicating their evaluation whether such an application was necessary (Figure 3). With grouping a method in categories A (no first-time request) or D (no method based on a high-risk medical device), InEK states that a method is not relevant to a § 137h assessment, while categories B (InEK unable to assess whether it is a first-time request) and C (insufficient submitted information to assess the question) indicate that InEK could not evaluate whether a § 137h application was necessary. This applies to the 3 methods with status 1 in category B: “External stabilization framework for anastomosis of an AV shunt in the context of shunt surgery”, “Epiretinal retinal prosthesis with event-based camera”, and “Epiretinal retinal prosthesis or epiretinal retinal prosthesis with event-based camera”.
Below is the full list of status 1 technologies:
- Insertion of coated (covered) stents with bioactive surface for peripheral vessels
- Implantation of an intracardiac pulse generator
- Ascites treatment by means of a fully implantable pump
- Covered endoprostheses with bioactive surface for dialysis shunt revision
- Hemodynamically effective implant for the endovascular treatment of intracranial aneurysms and brain-supplying neck vessels
- Endobarrier for the treatment of obese type 2 diabetics
- Percutaneous mitral valve anulorrhaphy with clasp
- Intraaneurysmal hemodynamically effective implant for endovascular treatment of intracranial aneurysms
- Endovascular implantation of an internal AV shunt by means of magnetically guided high-frequency energy
- Endovascular mitral valve annuloplasty with annuloplasty tape
- Transmission of virus-specific donor immune cells after allogeneic stem cell transplantation
- Endovascular implantation of an extracorporeal centrifugal pump for circulatory system support
- Catheter-based implant for the treatment of left ventricular cardiac motility disorders
- Transapical mitral valve reconstruction by implantation of neochordae (PTFE)
- Lung volume reduction by means of bronchoscopic application of polymer foam
- Radionuclide therapy with lutetium 177-labeled prostate-specific membrane antigen (PSMA) in prostate cancer
- Implantation of a gastric pacemaker
- Temporomandibular joint replacement (total replacement)
- Hypoglossal nerve stimulation system for the treatment of obstructive sleep apnea syndrome (OSAS)
- Transapical implantation of an extracorporeal centrifugal pump for circulatory system support
- Atrial occlusion by transpericardial ligature
- Intraaortal balloon occlusion with extracorporeal circulation
- Therapy of scoliosis by means of magnetically controlled rods
- Implant for direct acoustic stimulation of the cochlea (DACI)
- External stabilization framework for anastomosis of an AV shunt in the context of shunt surgery
- Apicoaortal, valve-carrying conduit
- Insertion of coated (covered) stents with bioactive surface for peripheral and other vessels
- Minimally invasive LV reconstruction with a myocardial anchoring system
- Selective intravascular radionuclide therapy (SIRT) with holmium 166-labeled microspheres for radioembolisation
- Insertion of coated (covered) stents with bioactive surface for intraabdominal, cranial or peripheral vessels
- Implantation of growing heart valves
- Intracavitary radiotherapy with iodine 125
- Endovascular mitral valve annuloplasty with seam anchoring
- Epiretinal retinal prosthesis
- Insertion of coated (covered) stents with bioactive surface for visceral and supraaortal vessels
- Endovascular mitral valve annuloplasty
- Fetoscopic drainage therapy
- Pulmonary arterial banding, telemetrically adjustable
- Fetoscopic tracheal balloon lock in case of diaphragmatic hernia and premature tuberosity
- Keratoprosthesis, biologically coated
- Therapy of scoliosis by means of a growing screw-rod-system
- Auditory brainstem implant
- Endo-Exo-prosthesis
- Subretinal active implant
- Lock of umbilical cord and intrafetal vessels by percutaneous ultrasound-controlled radiofrequency ablation or fetoscopic laser ablation
- Allogeneic hepatocyte transplantation
- Fetoscopic opening of narrowed semilunar valves and the foramen ovale
- Fetoscopic therapy of fetal supraventricular tachycardia and laryngeal or trachea occlusion
- Artificial larynx after total laryngectomy
- Epiretinal retinal prosthesis with event-based camera
- Fetoscopic patch closure at Spina bifida aperta
- Uterine shield closure after fetoscopic interventions
- Growth endoprostheses
- Auditory midbrain implant
- Epiretinal retinal prosthesis or epiretinal retinal prosthesis with event-based camera
- Lutetium-177- or yttrium-90-pentixafor therapy
- Radioimmunotherapy with anti-CD19, anti-CD45 and anti-CD66 antibodies
- Acoustic neuroma operation with simultaneous cochlear implantation
- Autologous matrix-induced hepatocyte transplantation
- Treatment of fatal epidermolysis bullosa junctionalis (M. Herlitz) by transplantation of haploidental bone marrow and skin of the same donor
- Combined renal and stem cell transplantation (living donation)
- Continuous amnion infusion by subcutaneous implanted port system
- Radionuclide therapy with iodine-131-azetidinylamide in metastatic adrenal carcinoma
- Radionuclide therapy with iodine-131-metomidate
- Radionuclide therapy with lutetium-177 bisphosphonate in bone metastases of the prostate carcinoma
- Uterus transplantation
- Complete face transplantation